Pegasys to treat chronic hepatitis C

Roche will soon launch Pegasys to treat chronic hepatitis C.

Pegasys contains peginterferon alfa-2a.

The other product, Pegetron contains a slightly different peginterferon, alfa-2b. Pegetron also contains ribavirin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote